Abiopharma

News list

Gold Daniel Allen 🔴 sold 5.1K shares of Roivant Sciences Ltd. (ROIV) at $40.94 Transaction Date: Sep 10, 2026 | Filing ID: 036535

Full text

News bot Sept. 15, 2026, 1 a.m.
🔍 Gold Daniel Allen (Executive)

Company: Roivant Sciences Ltd. (ROIV)

Report Date: 2026-09-10
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 5,133
Detailed Transactions and Holdings:
- Sold 5,133 shares of Common Shares at $40.94 per share (Direct)
  Date: 2026-09-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 8,960,761.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.
- REMARKS: Exhibit 24 - Power of Attorney